ARTA
CRDF icon

A.R.T. Advisors’s Cardiff Oncology CRDF Stock Holding History

A.R.T. Advisors’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-18,378
Closed -$28K – 1399
2019
Q3 		$28K Buy
18,378
+1,781
+11% +$3.47K ﹤0.01% 1356
2019
Q2 		$41K Sell
16,597
-2,082
-11% -$6.68K ﹤0.01% 1259
2019
Q1 		$70K Buy
18,679
+10,381
+125% +$37.1K ﹤0.01% 1200
2018
Q4 		$26K Sell
8,298
-13,073
-61% -$59.6K ﹤0.01% 1242
2018
Q3 		$104K Buy
+21,371
New +$101K ﹤0.01% 1271
2015
Q3 		– Sell
-823
Closed -$601K – 1388
2015
Q2 		$601K Buy
+823
New +$584K 0.02% 926

Other funds holding CRDF

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LWA
LWS Wealth Advisors Basking Ridge, New Jersey $266M AUM 12.97% 1-Year Est. Return
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
EP
Elkhorn Partners Omaha, Nebraska $157M AUM 11.91% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.21B AUM 26.82% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return